Roivant Sciences Ltd.
Close on Nov 18, 2026Market cap $27.98BP/E –Yield –
Roivant Sciences Arbutus Biopharma Corp. — Basic Ownership Stake by Quarter
Arbutus Biopharma Corp. — Basic Ownership Stake (%)
Roivant Sciences Arbutus Biopharma Corp. — Basic Ownership Stake: 19.0% in Q2 FY2026, down 1.0 pts from a year earlier. That is the lowest of the 18 quarters on record here.
Where the Q2 FY2026 figure comes from
“|| Arbutus 5 | 19 | % | 3 | 19 | % | 3”
Source: Form 10-Q (roiv-20260930.htm, filed 2026-11-09) ↗
Reported in Form 10-K / 10-Q.
quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Breakdown
What makes up arbutus Biopharma Corp. — Basic Ownership Stake
- Arbutus Biopharma Corp. — Fully Diluted Ownership Stake19.0% · Q2 FY2026
- Arbutus Biopharma — Exact Voting Ownership Stake (Footnote XBRL)19.0% · Q2 FY2026
- Arbutus Biopharma — Investment Fair Value (Level 1)186 · Q2 FY2026
- Arbutus Biopharma — Unrealized Gain (Loss) on Investment-0.80 · Q2 FY2026
- Arbutus Biopharma — Period-End Common Share Price4.78 · Q2 FY2026
Cite this data
StockData. (2026). Roivant Sciences Arbutus Biopharma Corp. — Basic Ownership Stake (%), quarterly Q1 FY2021–Q2 FY2026 [Data set]. Compiled from Roivant Sciences SEC filings and investor materials. https://stockdatahq.com/stocks/roiv/kpis/own-arbutus-basic
See every metric in the Roivant Sciences KPI table. Data updated Nov 16, 2026.
See a number that looks wrong?